These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 872149)

  • 41. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.
    Tokarska-Schlattner M; Zaugg M; Zuppinger C; Wallimann T; Schlattner U
    J Mol Cell Cardiol; 2006 Sep; 41(3):389-405. PubMed ID: 16879835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American symposium looks at new antineoplastic drug.
    Korcok M
    Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
    [No Abstract]   [Full Text] [Related]  

  • 43. Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
    Bielack SS; Erttmann R; Kempf-Bielack B; Winkler K
    Eur J Cancer; 1996 Sep; 32A(10):1652-60. PubMed ID: 8983270
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 46. How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients?
    Davutoglu V; Soydinc S; Akdemir I
    J Natl Med Assoc; 2004 May; 96(5):689-90. PubMed ID: 15160987
    [No Abstract]   [Full Text] [Related]  

  • 47. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.
    Strauss HG; Hemsen A; Karbe I; Lautenschläger C; Persing M; Thomssen C
    Anticancer Drugs; 2008 Jun; 19(5):541-5. PubMed ID: 18418221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxorubicin-induced cardiac toxicity.
    Doroshow JH
    N Engl J Med; 1991 Mar; 324(12):843-5. PubMed ID: 1997858
    [No Abstract]   [Full Text] [Related]  

  • 50. Anthracycline associated cardiac toxicity in children with malignancies.
    Mohta R; Saxena A; Jain Y; Gupta S; Thavaraj V; Narain S; Arya LS
    Indian Pediatr; 2002 Jun; 39(6):549-55. PubMed ID: 12084948
    [No Abstract]   [Full Text] [Related]  

  • 51. Cardiotoxicity of anthracyclines.
    Green MD; Speyer JL; Muggia FM
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):293-6. PubMed ID: 6584310
    [No Abstract]   [Full Text] [Related]  

  • 52. Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers.
    Kim RJ; Peterson G; Kulp B; Zanotti KM; Markman M
    Gynecol Oncol; 2005 May; 97(2):374-8. PubMed ID: 15863132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Doxorubicin in experimental and clinical heart failure.
    Christiansen S; Autschbach R
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):611-6. PubMed ID: 16901709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
    Wu HY; Kang YJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adriamycin cardiotoxicity].
    Recalcatri F; Villa A; Belli C
    G Ital Cardiol; 1982; 12(8):612-6. PubMed ID: 7169160
    [No Abstract]   [Full Text] [Related]  

  • 56. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Doxorubicin-induced cardiotoxicity: are there effective alternatives for prevention?].
    Canales MA
    Med Clin (Barc); 2010 Jan; 134(2):70-1. PubMed ID: 19896152
    [No Abstract]   [Full Text] [Related]  

  • 58. Early heart transplant in a child with advanced lymphoma.
    Morgan E; Pahl E
    Pediatr Transplant; 2002 Dec; 6(6):509-12. PubMed ID: 12453205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Adriamycin induced chronic cardiotoxicity: a morphological ultrastructural study on ventricular myocardium and conducting system of rabbit heart (author's transl)].
    Gandolfi A
    Ateneo Parmense Acta Biomed; 1976; 47(1):69-78. PubMed ID: 1016274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stroke due to doxorubicin-induced cardiac toxicity.
    Kara G; Taşoğlu O; Dizdar O; Altundağ K; Ozçakar L
    Med Oncol; 2009 Dec; 26(4):506-7. PubMed ID: 19031015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.